arginine and Carcinoma, Ductal, Breast

arginine has been researched along with Carcinoma, Ductal, Breast in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anyanwu, SN; Bunker, CH; Ezeome, ER; Ferrell, RE; Garte, SJ; Kuller, LH; Okobia, MN; Taioli, E; Uche, EE; Zmuda, JM	1
Balbín, M; Ferrando, AA; Fueyo, A; Hannon, GJ; López-Otín, C; Pendás, AM; Vizoso, F	1
Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG	1

Trials

1 trial(s) available for arginine and Carcinoma, Ductal, Breast

Article	Year
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. International journal of oncology, 1998, Volume: 12, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine	1998

Article

Year

Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.

International journal of oncology, 1998, Volume: 12, Issue:1

Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine

1998

Other Studies

2 other study(ies) available for arginine and Carcinoma, Ductal, Breast

Article	Year
Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC cancer, 2008, Nov-18, Volume: 8 Topics: Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glutamine; Humans; Nigeria; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Postmenopause; Premenopause; Receptors, Leptin; Risk Factors; Signal Transduction	2008
Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. The Journal of biological chemistry, 1996, Jun-28, Volume: 271, Issue:26 Topics: Arginine; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; Humans; Molecular Sequence Data; Oncogene Proteins; Point Mutation; Protein Binding; Structure-Activity Relationship; Tryptophan	1996

Article

Year

Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.

BMC cancer, 2008, Nov-18, Volume: 8

Topics: Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glutamine; Humans; Nigeria; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Postmenopause; Premenopause; Receptors, Leptin; Risk Factors; Signal Transduction

2008

Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.

The Journal of biological chemistry, 1996, Jun-28, Volume: 271, Issue:26

Topics: Arginine; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; Humans; Molecular Sequence Data; Oncogene Proteins; Point Mutation; Protein Binding; Structure-Activity Relationship; Tryptophan

1996